Edward L Barnes1,2, Millie D Long1,2,3, Michael D Kappelman2,3,4, Christopher F Martin1,3, Robert S Sandler1,3. 1. Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 2. Multidisciplinary Center for Inflammatory Bowel Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 3. Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 4. Division of Pediatric Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Abstract
BACKGROUND: High levels of patient activation (having the knowledge, skills, and confidence to effectively manage one's care), have been associated with improved outcomes in many chronic conditions. There have been few studies of the effects of activation in patients with inflammatory bowel disease (IBD). We performed a large, prospective Internet-based study to assess the relationship between patient activation level and clinical remission in patients with Crohn's disease or ulcerative colitis. METHODS: We administered the Patient Activation Measure (Insignia Health) to 1486 cohort participants. Patients completed a follow-up survey within 13 months (median, 189 days). We collected demographic and clinical data; anxiety and depression were assessed using Patient-Reported Outcomes Measurement Information System instruments. We used bivariate analyses and multivariable logistic regression to identify characteristics associated with low or high patient activation and to evaluate the association between levels of patient activation and subsequent disease activity. RESULTS: Higher anxiety (adjusted odds ratio [aOR], 0.32; 95% confidence interval [CI], 0.29-0.36) and depression (aOR, 0.33; 95% CI, 0.29-0.37) scores were associated with a decreased odds of high patient activation. After we adjusted for education status, smoking, medication use, and other confounders, we found that patients with high activation at baseline were more likely to be in clinical remission during the follow-up period (aOR, 1.71; 95% CI, 1.20-2.45). CONCLUSIONS: In a large, prospective Internet-based cohort of patients with IBD, we found a strong association between patient activation and clinical remission. These findings suggest that patient activation affects disease outcomes.
BACKGROUND: High levels of patient activation (having the knowledge, skills, and confidence to effectively manage one's care), have been associated with improved outcomes in many chronic conditions. There have been few studies of the effects of activation in patients with inflammatory bowel disease (IBD). We performed a large, prospective Internet-based study to assess the relationship between patient activation level and clinical remission in patients with Crohn's disease or ulcerative colitis. METHODS: We administered the Patient Activation Measure (Insignia Health) to 1486 cohort participants. Patients completed a follow-up survey within 13 months (median, 189 days). We collected demographic and clinical data; anxiety and depression were assessed using Patient-Reported Outcomes Measurement Information System instruments. We used bivariate analyses and multivariable logistic regression to identify characteristics associated with low or high patient activation and to evaluate the association between levels of patient activation and subsequent disease activity. RESULTS: Higher anxiety (adjusted odds ratio [aOR], 0.32; 95% confidence interval [CI], 0.29-0.36) and depression (aOR, 0.33; 95% CI, 0.29-0.37) scores were associated with a decreased odds of high patient activation. After we adjusted for education status, smoking, medication use, and other confounders, we found that patients with high activation at baseline were more likely to be in clinical remission during the follow-up period (aOR, 1.71; 95% CI, 1.20-2.45). CONCLUSIONS: In a large, prospective Internet-based cohort of patients with IBD, we found a strong association between patient activation and clinical remission. These findings suggest that patient activation affects disease outcomes.
Authors: Kelvin Thia; William A Faubion; Edward V Loftus; Tore Persson; Anders Persson; William J Sandborn Journal: Inflamm Bowel Dis Date: 2011-01 Impact factor: 5.325
Authors: Martha J Shively; Nancy J Gardetto; Mary F Kodiath; Ann Kelly; Tom L Smith; Carl Stepnowsky; Charles Maynard; Carolyn B Larson Journal: J Cardiovasc Nurs Date: 2013 Jan-Feb Impact factor: 2.083
Authors: Benjamin G Druss; Liping Zhao; Silke A von Esenwein; Joseph R Bona; Larry Fricks; Sherry Jenkins-Tucker; Evelina Sterling; Ralph Diclemente; Kate Lorig Journal: Schizophr Res Date: 2010-02-25 Impact factor: 4.939
Authors: Gregory W Munson; Kenneth A Wallston; Robert S Dittus; Theodore Speroff; Christianne L Roumie Journal: J Gen Intern Med Date: 2009-05-15 Impact factor: 5.128
Authors: W Benjamin Nowell; Peter A Merkel; Robert N McBurney; Kalen Young; Shilpa Venkatachalam; Dianne G Shaw; Angela Dobes; Emily Cerciello; Laura Kolaczkowski; Jeffrey R Curtis; Michael D Kappelman Journal: Patient Date: 2021-04-27 Impact factor: 3.883
Authors: Winnie Magadi; Courtney J Lightfoot; Katherine E Memory; Shalini Santhakumaran; Sabine N van der Veer; Nicola Thomas; Rachel Gair; Alice C Smith Journal: BMC Nephrol Date: 2022-01-26 Impact factor: 2.388
Authors: Katrin S Buerkle; Angharad Vernon-Roberts; Christine Ho; Michael Schultz; Andrew S Day Journal: Dig Dis Sci Date: 2022-05-05 Impact factor: 3.487
Authors: V Shane Pankratz; E Eunice Choi; Fares Qeadan; Donica Ghahate; Jeanette Bobelu; Robert G Nelson; Thomas Faber; Vallabh O Shah Journal: J Diabetes Complications Date: 2020-10-09 Impact factor: 2.852